Charles Schwab Investment Management Inc. Increases Holdings in Teleflex Incorporated (NYSE:TFX)

Charles Schwab Investment Management Inc. grew its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 2.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 407,203 shares of the medical technology company's stock after buying an additional 8,525 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.88% of Teleflex worth $72,474,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Apollon Wealth Management LLC raised its position in Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company's stock worth $377,000 after purchasing an additional 55 shares during the period. SRS Capital Advisors Inc. raised its position in Teleflex by 0.3% in the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company's stock worth $4,844,000 after purchasing an additional 60 shares during the period. Tokio Marine Asset Management Co. Ltd. grew its stake in Teleflex by 4.5% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company's stock worth $375,000 after acquiring an additional 66 shares in the last quarter. HighTower Advisors LLC grew its stake in Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock worth $986,000 after acquiring an additional 66 shares in the last quarter. Finally, Huntington National Bank grew its stake in Teleflex by 32.5% in the 3rd quarter. Huntington National Bank now owns 310 shares of the medical technology company's stock worth $77,000 after acquiring an additional 76 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have commented on TFX. Bank of America downgraded shares of Teleflex from a "neutral" rating to an "underperform" rating and dropped their target price for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Morgan Stanley dropped their target price on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 5th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research note on Monday, December 16th. Truist Financial dropped their target price on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating on the stock in a research note on Monday, March 3rd. Finally, Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, Teleflex currently has a consensus rating of "Hold" and a consensus price target of $182.63.

Remove Ads

Teleflex Price Performance

Shares of TFX opened at $139.25 on Wednesday. The company has a market cap of $6.46 billion, a price-to-earnings ratio of 27.68, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.90. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company has a 50 day moving average of $169.58 and a two-hundred day moving average of $199.60.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.98%. Teleflex's dividend payout ratio (DPR) is 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.